Sally C. Pipes
Commentary
Enabling The Next Biomedical Revolution
In his State of the Union address President Obama singled out biomedical innovation as a key driver of America’s future prosperity. This sector has indeed generated tens of thousands of jobs, attracted billions in investment and created advanced medical treatments for Americans. A promising new area of biomedicine, called biologics, ...
Business & Economics
A War That Has Ended
On any trip to the United Kingdom one must allow for the element of surprise. Last month I discovered a new perspective on what we might call womens studies. Womens aspiration to marry up, if they can, to a man who is better-educated and higher-earning, persists in most European countries, ...
Commentary
Obamacare Is Already Falling Apart
Last week, the House of Representatives voted by a wide margin — 245 to 189 — to repeal the president’s landmark health reform package. It’s unclear whether Senate Majority Leader Harry Reid, D-Nev., will bring the measure up in the upper body. But even if he doesn’t, the law is ...
Commentary
Choosy about right to choose
Jan. 22 marks the 38th anniversary of the U.S. Supreme Court’s Roe v. Wade decision, which guaranteed a woman’s right to choose to have an abortion. On this date annually, both sides of the abortion controversy confront each other over one of America’s most contentious issues. Liberal Democrats vigorously defend ...
Commentary
Hospitals lure doctors away from private practice
While making the case for his health reform package, President Obama argued that his proposal would make life easier for small-business owners. Unfortunately, Obamacare threatens to undermine a group of small-business owners that is perhaps more important than any other to his reform effort doctors in private practice. The ...
Business & Economics
Good Riddance to the Paycheck Fairness Act
Republicans in the Senate have successfully blocked the Paycheck Fairness Act. That is something to celebrate in 2011 because the Act had little to do with fairness. It would have empowered the federal government to regulate compensation and work arrangements in private businesses. Supporters lament that Congress has missed a ...
Commentary
Have-nots lose on Avastin ruling
The U.S. Food and Drug Administration did something highly unusual on Dec. 16: It revoked its previously granted approval for using a drug called Avastin to treat late-stage metastatic breast cancer. The FDA’s decision dimmed the lights on the Christmas trees of some 17,500 breast-cancer patients whose doctors prescribed Avastin ...
Commentary
American Patients, Get Ready to Wait
Real Clear Politics, December 22, 2009 USA Today, December 24, 2009 With the health reform debate moving apace in the Senate, the president and his political allies appear to be well on their way to implementing a government remake of the U.S. healthcare system. The situation for ordinary patients isn’t ...
Commentary
The Fatal Move From The FDA
On Dec. 17 the Food and Drug Administration is expected to take the radical step of revoking approval for an advanced drug in the treatment of one of the country’s most deadly diseases. Avastin, an advanced treatment for late-stage breast cancer, made it through the FDA approval process back in ...
Commentary
FDA’s Decision On Avastin Will Set the Standard
Later this month, the Food and Drug Administration will issue a ruling that will be a major test of the credibility of promises the Obama administration has made about the future of Medicare under health reform. At a Senate Finance Committee hearing in November, the new chief of Medicare and ...
Enabling The Next Biomedical Revolution
In his State of the Union address President Obama singled out biomedical innovation as a key driver of America’s future prosperity. This sector has indeed generated tens of thousands of jobs, attracted billions in investment and created advanced medical treatments for Americans. A promising new area of biomedicine, called biologics, ...
A War That Has Ended
On any trip to the United Kingdom one must allow for the element of surprise. Last month I discovered a new perspective on what we might call womens studies. Womens aspiration to marry up, if they can, to a man who is better-educated and higher-earning, persists in most European countries, ...
Obamacare Is Already Falling Apart
Last week, the House of Representatives voted by a wide margin — 245 to 189 — to repeal the president’s landmark health reform package. It’s unclear whether Senate Majority Leader Harry Reid, D-Nev., will bring the measure up in the upper body. But even if he doesn’t, the law is ...
Choosy about right to choose
Jan. 22 marks the 38th anniversary of the U.S. Supreme Court’s Roe v. Wade decision, which guaranteed a woman’s right to choose to have an abortion. On this date annually, both sides of the abortion controversy confront each other over one of America’s most contentious issues. Liberal Democrats vigorously defend ...
Hospitals lure doctors away from private practice
While making the case for his health reform package, President Obama argued that his proposal would make life easier for small-business owners. Unfortunately, Obamacare threatens to undermine a group of small-business owners that is perhaps more important than any other to his reform effort doctors in private practice. The ...
Good Riddance to the Paycheck Fairness Act
Republicans in the Senate have successfully blocked the Paycheck Fairness Act. That is something to celebrate in 2011 because the Act had little to do with fairness. It would have empowered the federal government to regulate compensation and work arrangements in private businesses. Supporters lament that Congress has missed a ...
Have-nots lose on Avastin ruling
The U.S. Food and Drug Administration did something highly unusual on Dec. 16: It revoked its previously granted approval for using a drug called Avastin to treat late-stage metastatic breast cancer. The FDA’s decision dimmed the lights on the Christmas trees of some 17,500 breast-cancer patients whose doctors prescribed Avastin ...
American Patients, Get Ready to Wait
Real Clear Politics, December 22, 2009 USA Today, December 24, 2009 With the health reform debate moving apace in the Senate, the president and his political allies appear to be well on their way to implementing a government remake of the U.S. healthcare system. The situation for ordinary patients isn’t ...
The Fatal Move From The FDA
On Dec. 17 the Food and Drug Administration is expected to take the radical step of revoking approval for an advanced drug in the treatment of one of the country’s most deadly diseases. Avastin, an advanced treatment for late-stage breast cancer, made it through the FDA approval process back in ...
FDA’s Decision On Avastin Will Set the Standard
Later this month, the Food and Drug Administration will issue a ruling that will be a major test of the credibility of promises the Obama administration has made about the future of Medicare under health reform. At a Senate Finance Committee hearing in November, the new chief of Medicare and ...
